This content is provided by Jonathan Sherman.
Co-Chair of the firm’s Cannabis Group. Assists a broad range of cannabis industry participants with an emphasis on mergers and acquisitions, corporate finance and go-public transactions, joint ventures, alternative financing and other commercial transactions for cannabis producers, applicants and ancillary businesses. Acts for public companies, private companies and investment dealers in domestic and cross-border transactions and advises issuers with respect to general corporate and securities law matters. Regular contributor to the firm’s Canadian Cannabis and Life Sciences blog and is regularly called upon as a thought leader in the cannabis industry.
